1.60
price up icon5.26%   0.08
after-market After Hours: 1.54 -0.06 -3.75%
loading
22nd Century Group, Inc. stock is traded at $1.60, with a volume of 232.26K. It is up +5.26% in the last 24 hours and down -11.11% over the past month. 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$1.52
Open:
$1.51
24h Volume:
232.26K
Relative Volume:
0.13
Market Cap:
$6.05M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.0258
EPS:
-61.9139
Net Cash Flow:
$-16.12M
1W Performance:
-3.03%
1M Performance:
-11.11%
6M Performance:
+79.76%
1Y Performance:
-92.07%
1-Day Range:
Value
$1.50
$1.60
1-Week Range:
Value
$1.46
$1.66
52-Week Range:
Value
$0.432
$21.38

22nd Century Group, Inc. Stock (XXII) Company Profile

Name
Name
22nd Century Group, Inc.
Name
Phone
716-270-1523
Name
Address
8560 Main Street, Williamsville, NY
Name
Employee
79
Name
Twitter
@_xxiicentury
Name
Next Earnings Date
2024-12-12
Name
Latest SEC Filings
Name
XXII's Discussions on Twitter

Compare XXII with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
XXII
22nd Century Group, Inc.
1.60 5.75M 29.78M -39.94M -16.12M -61.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-21-22 Initiated Alliance Global Partners Buy
Jun-15-22 Initiated Craig Hallum Buy
Mar-08-22 Initiated ROTH Capital Buy
Jul-23-21 Initiated Cowen Outperform
Oct-16-17 Reiterated Chardan Capital Markets Buy
Aug-11-16 Reiterated Chardan Capital Markets Buy
View All

22nd Century Group, Inc. Stock (XXII) Latest News

pulisher
10:46 AM

Can machine learning forecast 22nd Century Group Inc. recoveryEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com

10:46 AM
pulisher
10:29 AM

How 22nd Century Group Inc. stock reacts to job market dataJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com

10:29 AM
pulisher
09:56 AM

Can 22nd Century Group Inc. stock double in next 5 yearsRate Cut & Daily Profit Maximizing Trade Tips - newser.com

09:56 AM
pulisher
09:52 AM

Can volume confirm reversal in 22nd Century Group Inc.Market Risk Analysis & AI Driven Price Predictions - newser.com

09:52 AM
pulisher
08:30 AM

Is 22nd Century Group Inc. still worth holding after the dip2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com

08:30 AM
pulisher
01:26 AM

Is 22nd Century Group Inc. stock positioned for digital transformationForecast Cut & Long-Term Growth Plans - newser.com

01:26 AM
pulisher
Oct 12, 2025

Is this a good reentry point in 22nd Century Group Inc.Weekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Chart based analysis of 22nd Century Group Inc. trendsJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Visual trend scoring systems applied to 22nd Century Group Inc.2025 Analyst Calls & Weekly Top Gainers Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What Fibonacci levels say about 22nd Century Group Inc. reboundJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Reversal indicators forming on 22nd Century Group Inc. stockDividend Hike & Stepwise Swing Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Technical analysis overview for 22nd Century Group Inc. stockEarnings Recap Summary & Proven Capital Preservation Methods - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:06:40 - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

22nd Century shares rise as company announces debt-free balance sheet and new growth capital - MSN

Oct 07, 2025
pulisher
Oct 06, 2025

Is 22nd Century Group Inc a good long term investmentRisk Management Strategies & Exceptional Profit Growth - earlytimes.in

Oct 06, 2025
pulisher
Oct 05, 2025

Can you recover from losses in 22nd Century Group Inc.Jobs Report & Growth Oriented Trading Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Pattern recognition hints at 22nd Century Group Inc. upsideJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Identifying reversal signals in 22nd Century Group Inc.Portfolio Update Report & Growth Oriented Trading Recommendations - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

22nd Century Group Backs FDA’s Proposed Reduced Nicotine Standard - Tobacco Reporter

Oct 01, 2025
pulisher
Sep 30, 2025

22nd Century Group backs FDA’s proposed nicotine reduction standard By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

22nd Century Group backs FDA’s proposed nicotine reduction standard - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

22nd Century Submits Comments to FDA in Support of Proposed Reduced Nicotine Content Mandate - The Manila Times

Sep 30, 2025
pulisher
Sep 30, 2025

22nd Century Group, Inc. Supports FDA's Proposed Tobacco Product Standard Aimed at Reducing Smoking-Related Deaths and Economic Costs - Quiver Quantitative

Sep 30, 2025
pulisher
Sep 30, 2025

$600 Billion Annual Health Impact: 22nd Century Backs FDA Plan to Slash Nicotine in All US Cigarettes - Stock Titan

Sep 30, 2025
pulisher
Sep 28, 2025

22nd Century Group Hits New 52-Week Low at $1.56 Amidst Declining Sales - Markets Mojo

Sep 28, 2025
pulisher
Sep 26, 2025

22nd Century Settles $9.5M Insurance Claim, Eyes 2026 Profitability - Tobacco Reporter

Sep 26, 2025
pulisher
Sep 25, 2025

XXII Shows Promise: Is It Time to Buy? - timothysykes.com

Sep 25, 2025
pulisher
Sep 25, 2025

Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 25, 2025
pulisher
Sep 25, 2025

22nd Century Settles Insurance Litigation for $9.5M - TipRanks

Sep 25, 2025
pulisher
Sep 25, 2025

22nd Century Group Stock Rockets 30% Premarket On Scoring $9.5M Insurance Payday, Retail Traders Pile In - Stocktwits

Sep 25, 2025
pulisher
Sep 25, 2025

22nd Century Secures $9.5 Million Cash Proceeds from Settlement of Insurance Claim - The Manila Times

Sep 25, 2025
pulisher
Sep 24, 2025

22nd Century Group settles insurance claim for $9.5 million By Investing.com - Investing.com Nigeria

Sep 24, 2025

22nd Century Group, Inc. Stock (XXII) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):